HomeCompaniesProfile

Correlia Biosystems

Next-gen blood testing to provide 1000x more data to pharma companies 


Company Size

11 - 50 employees

Year Founded

Not Specified


About Correlia Biosystems

Correlia Biosystems is a UC Berkeley spinoff company based in Berkeley, CA. Correlia develops innovative microscale tools that accelerate rapid quantification of biomolecules.

Our versatile "SimpleScan" technology opens up new biological questions from one microliter of sample, with rapid results that allow for dynamic monitoring of protein expression profiles (rather than simple end-point measurement). Applications range from enabling next-gen proteomic data sets to point-of-care diagnostics.

Founders & Key People

Akwasi Apori

Akwasi Apori

Co-founder of Correlia Biosystems

Samuel Tia

Samuel Tia

Co-founder of Correlia Biosystems

Kursad Araz

Kursad Araz

Co-founder of Correlia Biosystems

Share This Profile

More Companies

Glimpse

Glimpse is the system of action for CPG retail operations

CoVerified

Using infection data to keep organizations safe

Baubap

Smart micro financing for everyone

Shepherd

Modernizing commercial insurance

Genomelink

DNA App Store

Clear Gene

Our tests help eradicate cancer by telling doctors whether they got…

BEAMSTART

BEAMSTART is a global entrepreneurship community, serving as a catalyst for innovation and collaboration. With a mission to empower entrepreneurs, we offer exclusive deals with savings totaling over $1,000,000, curated news, events, and a vast investor database. Through our portal, we aim to foster a supportive ecosystem where like-minded individuals can connect and create opportunities for growth and success.

© Copyright 2026 BEAMSTART. All Rights Reserved.